Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study
暂无分享,去创建一个
B. Pégourié | O. Decaux | X. Leleu | C. Leyronnas | J. Bosson | G. Pernod | C. Zarnitsky | B. Royer | P. Rodon | L. Karlin | M. Tiab | E. Voog | F. Orsini-Piocelle | L. Benboubker | E. Boyle | B. Slama | M. Cliquennois | J. Fuzibet | B. Bareau | Sophie Auger-Quittet | K. Belhadj-Merzoug | P. Rey